Results 151 to 160 of about 6,227,293 (250)

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

open access: yesMolecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David   +12 more
wiley   +1 more source

Reprogramming tumor cells with LCOR mRNA nanotherapy to enhance immunotherapy

open access: yesMolecular Oncology, EarlyView.
LCOR (Ligand‐dependent corepressor) mRNA encapsulated in polymeric nanoparticles restores LCOR activity in tumor cells, constraining aggressive tumor cell states and increasing tumor immunogenicity. This reprogramming makes tumor cells more vulnerable to T‐cell attack and enhances their response to immune‐checkpoint immunotherapy.
Gabriel Serra‐Mir   +9 more
wiley   +1 more source

Investigation of system latency detection threshold of virtual auditory display

open access: yes, 2006
Presented at the 12th International Conference on Auditory Display (ICAD), London, UK, June 20-23, 2006.Presented at the 12th International Conference on Auditory Display (ICAD), London, UK, June 20-23, 2006.It is important in a virtual auditory display (
Iwaya, Y., Suzuki, Y., Yairi, S.
core  

Optimization of seminal extracellular vesicle isolation protocols for cancer biomarker analysis using proteomic profiling

open access: yesMolecular Oncology, EarlyView.
This paper shows that size‐exclusion chromatography and sequential centrifugation applied to seminal plasma enrich for different populations of extracellular vesicles. This may significantly affect the detection and analysis of extracellular vesicle‐associated cancer biomarkers.
Elen Telumyan   +8 more
wiley   +1 more source

Yeast surface display-based screening and preliminary characterization of nectin-4-targeting nanobodies for bladder cancer. [PDF]

open access: yesBMC Biotechnol
Wen J   +14 more
europepmc   +1 more source

Engineering IL‐4 resistant proinflammatory human myeloid cells for cancer immunotherapy

open access: yesMolecular Oncology, EarlyView.
We developed a scalable workflow to generate proinflammatory human myeloid cells. CRISPR/Cas9‐edited CD34+ hematopoietic stem and progenitor cells were expanded and differentiated with M‐CSF. Deletion of STAT6 or STAT6/NFKB1 enhanced macrophage proinflammatory gene expression and cytokine secretion in the presence of IL‐4 while maintaining antibody ...
Theresa Barberi, Alan D. Friedman
wiley   +1 more source

Spatial Auditory Displays: Substitution and Complemenarity to Visual Displays

open access: yes, 2014
Presented at the 20th International Conference on Auditory Display (ICAD2014), June 22-25, 2014, New York, NY.Presented at the 20th International Conference on Auditory Display (ICAD2014), June 22-25, 2014, New York, NY.The primary goal of this research ...
Godfroy-Cooper, Martine   +2 more
core  

Repurposing the bacterial surface display technology for drug delivery. [PDF]

open access: yesAdv Drug Deliv Rev
Yang S   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy